Zadno Reza's Form 4/A amendment
AmendedPROCEPT BioRobotics Corp (PRCT) · filed Apr 19, 2024
- Accession no.
- 0001628280-24-017006
- Filed
- Apr 19, 2024
- Trade date
- Mar 6, 2024
- Filing delay
- 44 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 7, 2024
This filing lists 1 non-derivative transaction and 1 derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market sales total $428.4K. It was filed 44 days after the trade.
This amendment restates part of 0001628280-24-009763 (filed Mar 7, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zadno RezaCIK 0001632326 | Director, Officer (President, CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | AGrant or awardAcquired | +48,575 | $0.00 | $0 | 249,531 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | AGrant or awardAcquired | +42,311 | $0.00 | $0 | 42,311 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001628280-24-009763 (filed Mar 7, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | SSaleDisposed | −9,179 | $46.67F3 | −$428,383.93 | 246,710 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
The price reported in Column 4 is a weighted average price.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
- F2
This Form 4 amendment corrects a clerical error in the number of shares of common stock granted in the form of RSUs to the reporting person on March 6, 2024. The incorrect total common stock share amount was also reported in one subsequent transaction on the original Form 4, and one subsequent Form 4 filed by the reporting person after the original Form 4 was filed.
- F3
This Form 4 amendment corrects a clerical error in the number of shares underlying the stock option granted to the reporting person on March 6, 2024.
- F4
1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.